The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . Despite its groundbreaking success and impact of countless in sales, the intellectual property end has opened the door for competing medications, substantially eroding profit prospects . This shift raise